Image_2_The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis.tiff

Introduction

This meta-analysis aims to provide evidence-based medical evidence for formulating rational treatment strategies and evaluating the prognosis of brain metastasis (BM) patients by assessing the effectiveness of the graded prognostic assessment (GPA) model in predicting the survival prognosis of patients with BM after whole-brain radiotherapy (WBRT).

Methods

A comprehensive search was conducted in multiple databases, including the China Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), PubMed, Wanfang database, Cochrane Library, Web of Science, and Embase. Cohort studies that met the inclusion and exclusion criteria were selected. The quality of the included literature was evaluated using the Newcastle-Ottawa Scale, and all statistical analyses were performed with R version 4.2.2. The effect size (ES) was measured by the hazard ratio (HR) of overall survival (OS). The OS rates at 3, 6, 12, and 24 months of patients with BM were compared between those with GPAs of 1.5–2.5, 3.0, and 3.5–4.0 and those with GPAs of 0–1 after WBRT.

Results

A total of 1,797 participants who underwent WBRT were included in this study. The meta-analysis revealed a significant association between GPA and OS rates after WBRT: compared with BM patients with GPA of 0–1, 3-month OS rates after WBRT were significantly higher in BM patients with GPA of 1.5–2.5 (HR = 0.48; 95% CI: 0.40–0.59), GPA of 3 (HR = 0.38; 95% CI: 0.25–0.57), and GPA of 3.5–4 (HR = 0.28; 95% CI: 0.15–0.52); 6-month OS rates after WBRT were significantly higher in BM patients with GPA of 1.5–2.5 (HR = 0.48; 95% CI: 0.41–0.56), GPA of 3 (HR = 0.33; 95% CI: 0.24–0.45), and GPA of 3.5–4 (HR = 0.24; 95% CI: 0.16–0.35); 12-month OS rates after WBRT were significantly higher in BM patients with GPA of 1.5–2.5 (HR = 0.49; 95% CI: 0.41–0.58), GPA of 3 (HR = 0.48; 95% CI: 0.32–0.73), and GPA of 3.5–4 (HR = 0.31; 95% CI: 0.12–0.79); and 24-month OS rates after WBRT were significantly higher in BM patients with GPA of 1.5–2.5 (HR = 0.49; 95% CI: 0.42–0.58), GPA of 3 (HR = 0.49; 95% CI: 0.32–0.74), and GPA of 3.5–4 (HR = 0.38; 95% CI: 0.15–0.94).

Conclusion

BM patients with higher GPAs generally exhibited better prognoses and survival outcomes after WBRT compared to those with lower GPAs.

Systematic review registration

https://www.crd.york.ac.uk/prospero/, identifier CRD42023422914.